Wall Street Zen upgraded shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) from a hold rating to a buy rating in a research note published on Saturday morning. Several other research analysts have also recently issued reports on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Esperion Therapeutics in a report […]

Wall Street Zen downgraded shares of Organigram Global (NASDAQ:OGI – Free Report) from a hold rating to a sell rating in a report published on Saturday. A number of other equities analysts have also commented on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Organigram Global in a research note on […]

Wall Street Zen upgraded shares of Cullinan Therapeutics (NASDAQ:CGEM – Free Report) from a sell rating to a hold rating in a research note published on Saturday morning. Several other analysts also recently commented on CGEM. HC Wainwright lifted their target price on shares of Cullinan Therapeutics from $26.00 to $27.00 and gave the stock […]

Wall Street Zen upgraded shares of Smithfield Foods (NASDAQ:SFD – Free Report) from a hold rating to a buy rating in a report released on Saturday. A number of other analysts also recently weighed in on the company. Morgan Stanley set a $29.00 price objective on Smithfield Foods and gave the company an “overweight” rating […]

Wall Street Zen lowered shares of DBV Technologies (NASDAQ:DBVT – Free Report) from a hold rating to a sell rating in a report issued on Saturday. Several other equities analysts have also weighed in on the company. Cantor Fitzgerald set a $48.00 price target on DBV Technologies in a research note on Wednesday, December 17th. […]

Wall Street Zen upgraded shares of Innovation Beverage Group (NASDAQ:IBG – Free Report) from a sell rating to a hold rating in a research note published on Saturday morning. Innovation Beverage Group Stock Performance IBG stock opened at $3.73 on Friday. The company’s 50 day moving average price is $9.78 and its 200 day moving […]

Wall Street Zen upgraded shares of BCB Bancorp, Inc. (NJ) (NASDAQ:BCBP – Free Report) from a strong sell rating to a hold rating in a research report released on Saturday morning. Several other brokerages have also issued reports on BCBP. Keefe, Bruyette & Woods lowered their target price on BCB Bancorp, Inc. (NJ) from $9.50 […]